KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-cash Items (2016)

AbbVie (ABBV) has disclosed Non-cash Items for 4 consecutive years, with $51.0 million as the latest value for Q2 2016.

  • Quarterly Non-cash Items rose 122.08% to $51.0 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $51.0 million through Jun 2016, up 122.08% year-over-year, with the annual reading at $21.1 million for FY2015, 17.28% down from the prior year.
  • Non-cash Items for Q2 2016 was $51.0 million at AbbVie, down from $519.0 million in the prior quarter.
  • The five-year high for Non-cash Items was $1.0 billion in Q4 2014, with the low at $5.0 million in Q2 2014.
  • Average Non-cash Items over 4 years is $246.5 million, with a median of $37.4 million recorded in 2013.
  • The sharpest move saw Non-cash Items crashed 87.09% in 2014, then skyrocketed 2011.56% in 2016.
  • Over 4 years, Non-cash Items stood at $912.0 million in 2013, then grew by 14.47% to $1.0 billion in 2014, then crashed by 35.44% to $674.0 million in 2015, then plummeted by 92.43% to $51.0 million in 2016.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $51.0 million, $519.0 million, and $674.0 million for Q2 2016, Q1 2016, and Q4 2015 respectively.